Laquinimod ameliorates secondary brain inflammation
Accumulating evidence suggests that a degenerative processes within the brain can trigger the formation of new, focal inflammatory lesions in Multiple Sclerosis (MS). Here, we used a novel pre-clinical MS animal model to test whether the amelioration of degenerative brain events reduces the secondar...
Main Authors: | Julia Nedelcu, Christin Reinbach, Philipp Riedler, Matthias Brendel, Axel Rominger, Joel Kaye, Newshan Behrangi, Zhan Jiangshan, Christoph Schmitz, Markus Kipp |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-02-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096999611930350X |
Similar Items
-
Laquinimod Supports Remyelination in Non-Supportive Environments
by: Stella Nyamoya, et al.
Published: (2019-10-01) -
Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
by: Anna T. Wilmes, et al.
Published: (2018-06-01) -
Neuroimmunomodulatory properties of laquinimod
by: P.G. Amrutha, et al.
Published: (2024-03-01) -
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS
by: Tjalf Ziemssen, et al.
Published: (2017-08-01) -
The Cuprizone Model: Dos and Do Nots
by: Jiangshan Zhan, et al.
Published: (2020-03-01)